Barthel Petra, Schneider Raphael, Bauer Axel, Ulm Kurt, Schmitt Claus, Schömig Albert, Schmidt Georg
1 Medizinische Klinik der Technischen Universität München, Ismaninger Strabetae 22, 81675 München, Germany.
Circulation. 2003 Sep 9;108(10):1221-6. doi: 10.1161/01.CIR.0000088783.34082.89. Epub 2003 Aug 25.
Retrospective postinfarction studies revealed that decreased heart rate turbulence (HRT) indicates increased risk for subsequent death. This is the first prospective study to validate HRT in a large cohort of the reperfusion era.
One thousand four hundred fifty-five survivors of an acute myocardial infarction (age <76 years) in sinus rhythm were enrolled. HRT onset (TO) and slope (TS) were calculated from Holter records. Patients were classified into the following HRT categories: category 0 if both TO and TS were normal, category 1 if either TO or TS was abnormal, or category 2 if both TO and TS were abnormal. The primary end point was all-cause mortality. During a follow-up of 22 months, 70 patients died. Multivariately, HRT category 2 was the strongest predictor of death (hazard ratio, 5.9; 95% CI, 2.9 to 12.2), followed by left ventricular ejection fraction (LVEF) < or =30% (4.5; 2.6 to 7.8), diabetes mellitus (2.5; 1.6 to 4.1), age > or =65 years (2.4; 1.5 to 3.9), and HRT category 1 (2.4; 1.2 to 4.9). LVEF < or =30% had a sensitivity of 27% at a positive predictive accuracy level of 23%. The combined criteria of LVEF < or =30%, HRT category 2 or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 2 had a sensitivity of 24% at a positive predictive accuracy level of 37%. The combined criteria of LVEF < or =30% or LVEF >30%, age > or =65 years, diabetes mellitus, and HRT category 1 or 2 had a sensitivity of 44% at a positive predictive accuracy level of 23%.
HRT is a strong predictor of subsequent death in postinfarction patients of the reperfusion era.
心肌梗死后的回顾性研究表明,心率震荡(HRT)减弱提示后续死亡风险增加。这是在再灌注时代的一大群患者中验证HRT的第一项前瞻性研究。
纳入1455例急性心肌梗死存活患者(年龄<76岁),且为窦性心律。通过动态心电图记录计算HRT起始(TO)和斜率(TS)。患者被分为以下HRT类别:TO和TS均正常为0类;TO或TS异常为1类;TO和TS均异常为2类。主要终点为全因死亡率。在22个月的随访期间,70例患者死亡。多因素分析显示,HRT 2类是最强的死亡预测因素(风险比为5.9;95%可信区间为2.9至12.2),其次是左心室射血分数(LVEF)≤30%(4.5;2.6至7.8)、糖尿病(2.5;1.6至4.1)、年龄≥65岁(2.4;1.5至3.9)以及HRT 1类(2.4;1.2至4.9)。LVEF≤30%在阳性预测准确率为23%时的敏感度为27%。LVEF≤30%、HRT 2类或LVEF>30%、年龄≥65岁、糖尿病以及HRT 2类的联合标准在阳性预测准确率为37%时的敏感度为24%。LVEF≤30%或LVEF>30%、年龄≥65岁、糖尿病以及HRT 1类或2类的联合标准在阳性预测准确率为23%时的敏感度为44%。
HRT是再灌注时代心肌梗死后患者后续死亡的有力预测因素。